How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?

Author(s):
Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Vanderlocht, J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H.; Otten, H.G.
Published
2016
Publication type
Article / Letter to editor
human leukocyte antigen antibodiesluminexsingle antigensolid-phase multiplex-bead assays
Date issued
2016-09-30
Language
English
Is part of
Hla (2016), Vol. 88, no. 3, p. 110-119
hdl
1887/114224
doi
10.1111/tan.12860